(RTTNews) - Biotechnology company Moderna, Inc. (MRNA) and Israeli pharma company Medison Pharma announced Monday a new agreement to commercialize the Moderna COVID-19 Vaccine across Central Eastern Europe and Israel in 20 markets.
The agreement covers the following countries: Poland, Czech Republic, Romania, Hungary, Bulgaria, Slovenia, Slovakia, Croatia, Estonia, Latvia, Lithuania, Serbia, Ukraine, Moldova, Albania, Bosnia and Herzegovina, Kosovo, North Macedonia, Montenegro, and Israel.
The new partnership with Medison Pharma will ensure successful delivery of Moderna's mRNA COVID-19 vaccine to the 20 markets.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
